COX15
Basic information
Region (hg38): 10:99710868-99732127
Links
Phenotypes
GenCC
Source:
- Leigh syndrome (Definitive), mode of inheritance: AR
- cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2 (Moderate), mode of inheritance: AR
- Leigh syndrome with leukodystrophy (Supportive), mode of inheritance: AR
- cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2 (Strong), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
- Leigh syndrome (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial complex IV deficiency, nuclear type 6 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Cardiovascular; Musculoskeletal; Neurologic | 2175025; 12474143; 15235026; 15863660; 21412973 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (20 variants)
- Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2 (2 variants)
- Leigh syndrome (1 variants)
- Inborn genetic diseases (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the COX15 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 96 | 100 | ||||
missense | 88 | 94 | ||||
nonsense | 10 | |||||
start loss | 0 | |||||
frameshift | 10 | 12 | ||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 12 | 12 | ||||
splice region | 5 | 11 | 16 | |||
non coding | 44 | 75 | 19 | 138 | ||
Total | 20 | 14 | 137 | 174 | 21 |
Highest pathogenic variant AF is 0.000283
Variants in COX15
This is a list of pathogenic ClinVar variants found in the COX15 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-99710917-C-T | Leigh syndrome | Uncertain significance (Jan 12, 2018) | ||
10-99710949-G-A | Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
10-99711101-C-CA | Mitochondrial complex IV deficiency, nuclear type 1 | Benign (Jun 14, 2016) | ||
10-99711101-C-CAA | Mitochondrial complex IV deficiency, nuclear type 1 | Conflicting classifications of pathogenicity (May 01, 2023) | ||
10-99711170-A-G | Leigh syndrome | Benign (Jan 13, 2018) | ||
10-99711225-A-G | Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
10-99711340-A-G | Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
10-99711628-C-G | Leigh syndrome | Uncertain significance (Jan 12, 2018) | ||
10-99711689-T-C | Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
10-99711730-T-C | Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
10-99711737-T-C | Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
10-99711748-C-A | Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
10-99711831-GA-G | Mitochondrial complex IV deficiency, nuclear type 1 | Uncertain significance (Jun 14, 2016) | ||
10-99711842-A-C | Leigh syndrome | Uncertain significance (Jan 12, 2018) | ||
10-99711886-T-C | Leigh syndrome | Uncertain significance (Jan 12, 2018) | ||
10-99711919-G-C | Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
10-99711938-C-T | Leigh syndrome | Benign (Jan 13, 2018) | ||
10-99711967-G-A | Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
10-99711992-G-A | Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
10-99711993-A-C | Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
10-99712097-A-G | Leigh syndrome | Uncertain significance (Jan 13, 2018) | ||
10-99712128-C-A | Leigh syndrome | Uncertain significance (Jan 12, 2018) | ||
10-99712286-C-G | Leigh syndrome | Uncertain significance (Apr 27, 2017) | ||
10-99712286-C-T | Leigh syndrome | Uncertain significance (Feb 09, 2018) | ||
10-99712305-C-T | Leigh syndrome | Uncertain significance (Jan 12, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
COX15 | protein_coding | protein_coding | ENST00000016171 | 9 | 20257 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.10e-13 | 0.0429 | 125617 | 0 | 131 | 125748 | 0.000521 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.262 | 208 | 219 | 0.950 | 0.0000123 | 2603 |
Missense in Polyphen | 72 | 80.559 | 0.89375 | 967 | ||
Synonymous | -0.177 | 87 | 84.9 | 1.02 | 0.00000448 | 870 |
Loss of Function | 0.348 | 21 | 22.8 | 0.921 | 0.00000128 | 253 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000945 | 0.000944 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.0000464 | 0.0000462 |
European (Non-Finnish) | 0.000687 | 0.000686 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000393 | 0.000392 |
Other | 0.00114 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in the biosynthesis of heme A. {ECO:0000269|PubMed:12474143}.;
- Disease
- DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:15235026, ECO:0000269|PubMed:15863660}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Thermogenesis - Homo sapiens (human);Oxidative phosphorylation - Homo sapiens (human);Porphyrin and chlorophyll metabolism - Homo sapiens (human);Hereditary Coproporphyria (HCP);Porphyria Variegata (PV);Congenital Erythropoietic Porphyria (CEP) or Gunther Disease;Acute Intermittent Porphyria;Porphyrin Metabolism;Electron Transport Chain;Heme biosynthesis;Metabolism of porphyrins;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.147
Intolerance Scores
- loftool
- 0.167
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 36.07
Haploinsufficiency Scores
- pHI
- 0.407
- hipred
- N
- hipred_score
- 0.326
- ghis
- 0.566
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.990
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cox15
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- mitochondrial electron transport, cytochrome c to oxygen;heme biosynthetic process;heme a biosynthetic process;respiratory gaseous exchange;respiratory chain complex IV assembly;cellular respiration;oxidation-reduction process;proton transmembrane transport
- Cellular component
- nucleus;mitochondrion;mitochondrial inner membrane;mitochondrial respirasome;integral component of membrane;cytochrome complex
- Molecular function
- cytochrome-c oxidase activity;protein binding;oxidoreductase activity, acting on the CH-CH group of donors;oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor